Ignite Creation Date:
2025-12-25 @ 3:10 AM
Ignite Modification Date:
2026-03-04 @ 8:23 PM
Study NCT ID:
NCT01338805
Status:
COMPLETED
Last Update Posted:
2021-03-05
First Post:
2011-04-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II BGG492 Capsule Extension for Partial Epilepsy
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Partial Onset Seizures | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Partial onset seizure | View |
| None | seizure frequency | View |
| None | nervous system diseases | View |
| None | central nervous system diseases | View |
| None | CNS | View |
| None | brain diseases | View |
| None | neurologic manifestations | View |
| None | adjunctive treatment | View |
| None | AEDs | View |
| None | antiepileptic drug | View |